Butalbital, Aspirin, and Caffeine Capsules, USP is supplied in capsule form for oral administration.
Each capsule contains the following active ingredients:
| butalbital, USP. .. .. .. .. .. ..
| aspirin, USP.. .. .. .. .. .. .. ..
| caffeine, USP. .. .. .. .. .. .. .
Butalbital, Aspirin, and Caffeine Capsules, USP is indicated for the relief of the symptom complex of tension (or muscle contraction) headache. Evidence supporting the efficacy and safety of Butalbital, Aspirin, and Caffeine Capsules, USP in the treatment of multiple recurrent headaches is unavailable. Caution in this regard is required because butalbital is habit-forming and potentially abusable.
Media Articles Related to Butalbital, Aspirin, and Caffeine (Butalbital / Aspirin / Caffeine)
Low Vitamin D Linked to Increased Headache Risk
Source: Medscape NeurologyHeadlines [2017.01.19]
Data from 2600 Finnish men showed that those with the lowest levels of serum 25-hydroxyvitamin D were more than twice as likely to report chronic headaches as those with the highest levels.
Medscape Medical News
Vitamin D deficiency increases risk of chronic headache
Source: Headache / Migraine News From Medical News Today [2017.01.04]
Vitamin D deficiency may increase the risk of chronic headache, according to a new study from the University of Eastern Finland. The findings were published in Scientific Reports.
Source: MedicineNet Dehydration Specialty [2016.11.30]
Title: Headache Remedies
Category: Diseases and Conditions
Created: 4/12/2016 12:00:00 AM
Last Editorial Review: 11/30/2016 12:00:00 AM
Visits to pediatric emergency departments for headache pain in children are on the rise
Source: Headache / Migraine News From Medical News Today [2016.10.24]
At 1 hospital, rates of emergency department visits and subsequent hospital admission doubled over a 7-year period.
Can You Blame Your Headaches on Your Thyroid?
Source: MedicineNet Hypothyroidism Specialty [2016.09.30]
Title: Can You Blame Your Headaches on Your Thyroid?
Category: Health News
Created: 9/29/2016 12:00:00 AM
Last Editorial Review: 9/30/2016 12:00:00 AM
Published Studies Related to Butalbital, Aspirin, and Caffeine (Butalbital / Aspirin / Caffeine)
Butalbital in the treatment of headache: history, pharmacology, and efficacy. [2001.11]
Analgesics containing butalbital compounded with aspirin, acetaminophen, and/or caffeine are widely used for the treatment of migraine and tension-type headache. The butalbital-containing compounds are efficacious in placebo-controlled trials among patients with episodic tension-type headaches.Because of concerns about overuse, medication-overuse headache, and withdrawal, their use should be limited and carefully monitored.
A protocol for butalbital, aspirin and caffeine (BAC) detoxification in headache patients. [1990.07]
The abuse of the combination drug containing butalbital 50 mg, aspirin 325 mg and caffeine 40 mg (or BAC), is commonly recognized by headache specialists as causing headaches. Despite this widespread problem, there is not a published treatment regimen for the BAC detoxification of patients.The other two patients were still BAC free 18 and 14 months after detoxification.
Clinical Trials Related to Butalbital, Aspirin, and Caffeine (Butalbital / Aspirin / Caffeine)
Metabolomic Fingerprint After Bariatric Surgery [Completed]
Background: Obesity is associated with multiple diseases. Bariatric surgery is the most
effective therapy for severe obesity that cannot only reduce body weight but also
Objective: The metabolic alterations associated with obesity and respective changes after
bariatric surgery are incompletely understood.
Design: In the longitudinal observational study, the investigator applied a 1H-NMR-based
global, untargeted metabolomics strategy on human serum samples that were collected before
and repeatedly up to one year after distinct bariatric procedures (sleeve gastrectomy,
proximal and distal Roux-en Y gastric bypass; RYGB). For comparison, the investigator also
analyzed serum samples from normal-weight and less obesity obese subjects that were matched
for 1-year postoperative BMI values of the surgical groups.
Page last updated: 2017-01-19